Eli Lilly (NYSE: LLY) stock has had plenty of good trading sessions over the past year or so, but Monday's sure wasn't among ...

Stock splits tend to create a lot of buzz in the market, especially when some of the most prominent companies announce a ...

Morgan Stanley analyst Terence Flynn notes that Novo Nordisk (NVO) reported CagriSema Phase 3 data in type two diabetes demonstrating weight ...

We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...

RiverPark Advisors, an investment advisory firm and sponsor of the RiverPark family of mutual funds, released its “RiverPark ...

Shares of Eli Lilly & Co. LLY slid 4.73% to $869.58 Friday, on what proved to be an all-around positive trading session for ...

Eli Lilly stock surges past $840, outperforming the S&P 500. Click here to learn why LLY stock is still undervalued and why ...

With Hims & Hers' main source of growth set to be extinguished, Citi analysts said its full-year guidance appeared ...

Eli Lilly (NYSE: LLY) stock defied today's market downturn, rising 2.6% through 11:15 a.m. ET on the back of two positive ...

Eli Lilly (NYSE: LLY) stock defied today's market ... It's as simple as that -- and good enough for a 2.6% stock price bump. The Motley Fool Stock Advisor analyst team just identified what they ...

Eli Lilly is buying a new drug and lowering prices ... It's as simple as that -- and good enough for a 2.6% stock price bump. Rich Smith has no position in any of the stocks mentioned.